Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Oskouei

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Stem Cells (Dayton, Ohio)|June 5, 2013
C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potentialErika B Rangel, Samirah A Gomes, Raul A Dulce, et al.
Journal of the American College of Cardiology|November 23, 2006
Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapyLuciano C Amado, Karl H Schuleri, Anastasios P Saliaris, et al.
Circulation Research|September 22, 2012
Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophyJinliang Li, Michael D Kritzer, Jennifer J Carlisle Michel, et al.
American Heart Journal|March 12, 2011
Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacyBarry Trachtenberg, Darcy L Velazquez, Adam R Williams, et al.
The Journal of Clinical Investigation|October 12, 2011
FGF23 induces left ventricular hypertrophyChristian Faul, Ansel P Amaral, Behzad Oskouei, et al.
JAMA|November 20, 2013
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trialAlan W Heldman, Darcy L DiFede, Joel E Fishman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Stem Cells (Dayton, Ohio)|June 5, 2013
C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potentialErika B Rangel, Samirah A Gomes, Raul A Dulce, et al.
Journal of the American College of Cardiology|November 23, 2006
Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapyLuciano C Amado, Karl H Schuleri, Anastasios P Saliaris, et al.
Circulation Research|September 22, 2012
Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophyJinliang Li, Michael D Kritzer, Jennifer J Carlisle Michel, et al.
American Heart Journal|March 12, 2011
Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacyBarry Trachtenberg, Darcy L Velazquez, Adam R Williams, et al.
The Journal of Clinical Investigation|October 12, 2011
FGF23 induces left ventricular hypertrophyChristian Faul, Ansel P Amaral, Behzad Oskouei, et al.
JAMA|November 20, 2013
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trialAlan W Heldman, Darcy L DiFede, Joel E Fishman, et al.
Pageof 1